ResearcherUniversity of HelsinkiNo recent work listed

Juho Pirhonen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8875-2917; OpenAlex author ID A5019283240. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-0396 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

György Marko‐Varga · 1 shared paper, 2022 · strength 0.13
- Paper Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-0396 ↗
Elina Ikonen · 1 shared paper, 2022 · strength 0.13
- Paper Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-0396 ↗
Hanna E. Seppänen · 1 shared paper, 2022 · strength 0.13
- Paper Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-0396 ↗
Caj H. Haglund · 1 shared paper, 2022 · strength 0.13
- Paper Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-0396 ↗
Pauli Antero Puolakkainen · 1 shared paper, 2022 · strength 0.13
- Paper Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-0396 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.